|Day Low/High||85.00 / 86.89|
|52 Wk Low/High||63.68 / 99.14|
Smith says Perrigo and Altaba are important investments.
For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant
The healthcare firm has agreed to sell its active pharmaceutical ingredients business and its Russia consumer healthcare international unit.
Stocks fall for their third day in a row.
Teva's not the only one struggling to stay afloat in Israel.
The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.
The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.
The top executives at these seven companies all left after pressure from activist investors in 2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.